Managed Access Programs for LEE011, Ribociclib

Conditions

• Breast Cancer

Eligibility Criteria

Sex

ALL

Age

1 Year - N/A

Healthy Volunteers

Not accepted

Interventions

• Ribociclib — DRUG
  Patients receive ribociclib

Study Details

The purpose of this registration is to list Managed Access Programs (MAPs) related to LEE011, Ribociclib

Key Dates

Status verified

Mar 2026

Central Contacts

• MAP requests are initiated by a licensed physician. https// www.novart is.com/healthcare-professionals/managed-access-programs
  +41613241111
  [email protected]
• Novartis Pharmaceuticals

Related Studies

• Collection of Blood From Patients With Cancer
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
• Harvesting Cells for Experimental Cancer Treatments
  Enrolling By Invitation · National Cancer Institute (NCI) · Bethesda, Maryland
• High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer
  Recruiting · Carol Fabian, MD · Kansas City, Kansas
• Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
  Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland